Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled and Delayed-Start Study of LY3314814 in Mild Alzheimer's Disease Dementia

NCT02783573 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02783573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02783573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled and Delayed-Start Study of LY3314814 in Mild Alzheimer's Disease Dementia
Lead sponsor
AstraZeneca
Phase
Phase 3
Overall status
Terminated
Start date
July 1, 2016
Completion date
September 28, 2018
Enrollment
1,722 (actual)
Sites
262

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease